Cartesian Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Cartesian Therapeutics, Inc. (RNAC) reported Diluted Shares Outstanding (Weighted Average) of 29.86 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 29.86M shares, a 12.91% increase year-over-year.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 26.86M shares, a 3.68% increase year-over-year.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 26.01M shares, a 1.01% increase year-over-year.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 26.00M shares, a 21.10% increase year-over-year.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 25.97M shares, a 49.63% increase from fiscal 2024.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 17.36M shares, a 235.72% increase from fiscal 2023.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 5.17M shares, a 96.46% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 145.87M shares, a 27.59% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 29.86M shares 10-Q · filed 2026-08-06 | 28.14M shares 10-Q · filed 2026-08-06 | 27.57M shares derived: average of 3 quarters · filed 2026-08-06 | 27.18M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 26.86M shares 10-Q · filed 2026-04-30 | 26.43M shares derived: average of 2 quarters · filed 2026-04-30 | 26.29M shares derived: average of 3 quarters · filed 2026-04-30 | 26.33M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 26.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 26.00M shares derived: average of 2 quarters · filed 2026-03-09 | 26.15M shares derived: average of 3 quarters · filed 2026-08-06 | 25.97M shares 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | 26.00M shares 10-Q · filed 2025-11-06 | 26.23M shares derived: average of 2 quarters · filed 2026-08-06 | 25.96M shares 10-Q · filed 2025-11-06 | 26.02M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 26.45M shares 10-Q · filed 2026-08-06 | 25.94M shares 10-Q · filed 2026-08-06 | 26.03M shares derived: average of 3 quarters · filed 2026-08-06 | 24.89M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 25.90M shares 10-Q · filed 2026-04-30 | 25.82M shares derived: average of 2 quarters · filed 2026-04-30 | 24.37M shares derived: average of 3 quarters · filed 2026-04-30 | 22.73M shares derived: average of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | 25.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 23.61M shares derived: average of 2 quarters · filed 2026-03-09 | 21.67M shares derived: average of 3 quarters · filed 2026-03-09 | 17.36M shares 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | 21.47M shares 10-Q · filed 2025-11-06 | 19.63M shares derived: average of 2 quarters · filed 2025-11-06 | 14.56M shares 10-Q · filed 2025-11-06 | 12.49M shares derived: average of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | 17.79M shares 10-Q · filed 2025-08-07 | 11.07M shares 10-Q · filed 2025-08-07 | 9.50M shares derived: average of 3 quarters · filed 2025-08-07 | 8.41M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 5.41M shares 10-Q · filed 2025-05-08 | 5.35M shares derived: average of 2 quarters · filed 2025-05-08 | 5.29M shares derived: average of 3 quarters · filed 2025-05-08 | 5.25M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 5.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 5.23M shares derived: average of 2 quarters · filed 2025-03-13 | 5.19M shares derived: average of 3 quarters · filed 2025-03-13 | 5.17M shares 10-K · filed 2025-03-13 | 155.11M shares 10-K · filed 2024-03-07 | |||
| 2023-09-30 | 5.16M shares 10-Q · filed 2024-11-07 | 154.80M shares 10-Q · filed 2023-11-13 | 5.14M shares derived: average of 2 quarters · filed 2024-11-07 | 5.13M shares 10-Q · filed 2024-11-07 | 153.87M shares 10-Q · filed 2023-11-13 | 41.88M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 5.11M shares 10-Q · filed 2024-08-08 | 153.44M shares 10-Q · filed 2023-08-17 | 5.11M shares 10-Q · filed 2024-08-08 | 153.40M shares 10-Q · filed 2023-08-17 | 54.12M shares derived: average of 3 quarters · filed 2024-08-08 | 78.80M shares derived: average of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | 5.11M shares 10-Q · filed 2024-05-08 | 153.35M shares 10-Q · filed 2023-05-04 | 78.62M shares derived: average of 2 quarters · filed 2024-05-08 | 103.36M shares derived: average of 3 quarters · filed 2024-05-08 | 114.65M shares derived: average of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | 152.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 152.49M shares derived: average of 2 quarters · filed 2024-03-07 | 151.16M shares derived: average of 3 quarters · filed 2024-03-07 | 145.87M shares 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | 152.85M shares 10-Q · filed 2023-11-13 | 150.68M shares derived: average of 2 quarters · filed 2023-11-13 | 143.79M shares 10-Q · filed 2023-11-13 | 136.69M shares derived: average of 4 quarters · filed 2024-03-07 | ||||
| 2022-06-30 | 148.51M shares 10-Q · filed 2023-08-17 | 136.97M shares 10-Q · filed 2023-08-17 | 131.30M shares derived: average of 3 quarters · filed 2024-03-07 | 127.27M shares derived: average of 4 quarters · filed 2024-03-07 | ||||
| 2022-03-31 | 127.57M shares 10-Q · filed 2023-05-04 | 122.70M shares derived: average of 2 quarters · filed 2024-03-07 | 120.19M shares derived: average of 3 quarters · filed 2024-03-07 | 120.44M shares derived: average of 4 quarters · filed 2024-03-07 | ||||
| 2021-12-31 | 117.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 116.50M shares derived: average of 2 quarters · filed 2024-03-07 | 118.06M shares derived: average of 3 quarters · filed 2024-03-07 | 114.33M shares 10-K · filed 2024-03-07 | ||||
| 2021-09-30 | 115.17M shares 10-Q · filed 2022-11-03 | 118.17M shares derived: average of 2 quarters · filed 2022-11-03 | 113.16M shares 10-Q · filed 2022-11-03 | 113.75M shares derived: average of 4 quarters · filed 2023-03-02 | ||||
| 2021-06-30 | 121.18M shares 10-Q · filed 2022-08-08 | 112.14M shares 10-Q · filed 2022-08-08 | 113.27M shares derived: average of 3 quarters · filed 2023-03-02 | 111.29M shares derived: average of 4 quarters · filed 2023-03-02 | ||||
| 2021-03-31 | 110.74M shares 10-Q · filed 2022-05-05 | 109.32M shares derived: average of 2 quarters · filed 2023-03-02 | 107.99M shares derived: average of 3 quarters · filed 2023-03-02 | 105.19M shares derived: average of 4 quarters · filed 2023-03-02 | ||||
| 2020-12-31 | 107.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 106.61M shares derived: average of 2 quarters · filed 2023-03-02 | 103.34M shares derived: average of 3 quarters · filed 2023-03-02 | 101.20M shares 10-K · filed 2023-03-02 | ||||
| 2020-09-30 | 105.33M shares 10-Q · filed 2021-11-09 | 101.06M shares derived: average of 2 quarters · filed 2021-11-09 | 98.97M shares 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | 96.79M shares 10-Q · filed 2021-08-12 | 95.75M shares 10-Q · filed 2021-08-12 | ||||||
| 2019-12-31 | 45.55M shares 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |